Table 1.
Comparison of clinical data between the MetS and control groups.
| MetS group | Control group | P value | |
|---|---|---|---|
| No. of cases | 651 | 727 | – |
| Sex (male/female) | 425 (65%)/226 (35%) | 442 (61%)/285 (39%) | 0.085 |
| Age (years) | 50.40 ± 10.74 | 51.23 ± 11.55 | 0.166 |
| BMI (kg/m2) | 26.78 ± 2.98 | 22.35 ± 2.44 | <0.001 |
| Waist circumference (cm) | 91.00 (85.00–97.00) | 77.00 (71.00–81.00) | <0.001 |
| WHR | 0.89 ± 0.05 | 0.82 ± 0.05 | <0.001 |
| Systolic BP (mmHg) | 134.00 (126.00–144.00) | 112.00 (104.00–120.00) | <0.001 |
| Diastolic BP (mmHg) | 82.00 (74.00–88.00) | 68.00 (62.00–74.00) | <0.001 |
| FPG (mmol/L) | 5.65 (5.21–6.20) | 5.02 (4.77–5.25) | <0.001 |
| FINS (mU/L) | 9.51 (7.17–13.61) | 6.42 (4.75–9.03) | <0.001 |
| TG (mmol/L) | 2.14 (1.62–2.84) | 0.98 (0.70–1.28) | <0.001 |
| TC (mmol/L) | 4.85 (4.27–5.38) | 4.50 (4.03–5.11) | <0.001 |
| HDL-C (mmol/L) | 1.03 (0.91–1.20) | 1.44 (1.28–1.65) | <0.001 |
| LDL-C (mmol/L) | 2.78 ± 0.82 | 2.57 ± 0.71 | 0.007 |
| Hcy (µmol/L) | 12.66 (10.34–16.18) | 10.36 (8.31–12.73) | <0.001 |
| HOMA-IR | 2.41 (1.76–3.53) | 1.40 (0.92–1.89) | <0.001 |
Values are mean ± SD or median (interquartile range).
MetS = metabolic syndrome; BMI = body mass index; WHR= waist-to-hip ratio; BP= blood pressure; FPG = fasting plasma glucose; FINS = fasting serum insulin; TG = triglycerides; TC = total cholesterol; HDL-C = high-density lipoprotein-cholesterol; LDL-C = low-density lipoprotein-cholesterol; Hcy = homocysteine; HOMA-IR = homeostasis model assessment of insulin resistance.